Bromomethylcyclopropane → 2,4-Dioxo-1,5-bis-(cyclopropylmethyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine
Reaktionsgleichung
[O:1]=[C:2]1[NH:8][C:7]2[CH:9]=[CH:10][CH:11]=[CH:12][C:6]=2[NH:5][C:4](=[O:13])[CH2:3]1.Br[CH2:15][CH:16]1[CH2:18][CH2:17]1>>[O:13]=[C:4]1[N:5]([CH2:15][CH:16]2[CH2:18][CH2:17]2)[C:6]2[CH:12]=[CH:11][CH:10]=[CH:9][C:7]=2[N:8]([CH2:15][CH:16]2[CH2:18][CH2:17]2)[C:2](=[O:1])[CH2:3]1Komponenten
3
Versuchsvorschrift
2,4-Dioxo-1,5-bis-(cyclopropylmethyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine was prepared following General Procedure 8-M using the product from Example 8-P, Step A and (bromomethyl)cyclopropane (Lancaster). Purification was by flash chromatography eluting with EtOAc/hexanes (3:7 gradient to straight EtOAc), then recrystalization from EtOAc/hexanes.
Aufarbeitung
- customPurification
- washeluting with EtOAc/hexanes (3:7 gradient to straight EtOAc)
- customrecrystalization from EtOAc/hexanes
Quellen und Nachweise
- ORD-Eintrag
- ord-dfd97be58ee5418db74edaefc2a7ecc7
- Quelldatensatz
- uspto-grants-2003_10
- Patentnummer
- US06632811B2
Notizen zur Reaktion
Wird geladen…